PAUL E SCHULMAN M.D. NPI 1639165541

NPI Information

  • NPI: 1639165541
  • Provider Name: PAUL E SCHULMAN, M.D.
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 315 MIDDLE COUNTRY RD
    SMITHTOWN, NY
    ZIP 11787
  • Phone: (631) 360-7778

Map and Directions

Get Directions

NPI Details

Paul E Schulman, M.D. is a rheumatology internal medicine in Smithtown, NY with 42 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Paul E Schulman, M.D. NPI is 1639165541. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: BOSTON UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1983

The provider's business location address is:

315 MIDDLE COUNTRY RD
SMITHTOWN, NY
ZIP 11787-817
Phone: (631) 360-7778
Fax: (631) 979-1609

The NPI 1639165541 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
  • Injection, tocilizumab, 1 mg (HCPCS:J3262)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
  • Injection, belimumab, 10 mg (HCPCS:J0490)
  • Injection, rituximab, 10 mg (HCPCS:J9312)
  • Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg (HCPCS:J7322)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Infusion, normal saline solution, 250 cc (HCPCS:J7050)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Aspiration and/or injection of fluid from large joint (HCPCS:20610)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose (HCPCS:J7321)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • X-ray of hand, minimum of 3 views (HCPCS:73130)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Injection into tendon or ligament (HCPCS:20550)
  • Injection of drug or substance into vein (HCPCS:96374)
  • X-ray of knee, 1-2 views (HCPCS:73560)
  • X-ray of hand, 2 views (HCPCS:73120)
  • X-ray of shoulder, minimum of 2 views (HCPCS:73030)
  • X-ray of hip, 2-3 views (HCPCS:73502)
  • Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
  • X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)

The enumeration date for this NPI number is 9/26/2005 and was last updated on 5/19/2014.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RR0500XInternal MedicineRheumatology161423NEW YORKYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
123E132MEDICARE PINNEW YORK
2A61398MEDICARE UPINNEW YORK
301835249MEDICAIDNEW YORK

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.